FDMT

MKT CAP:$508M

4D Molecular Therapeutics Inc

Market Cap

$508M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$8.64+$1.32 (+18.03%)

Jun 5, 2026

52W High $12.2752W Low $3.71

Company Details

4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and ...

CEO

—

IPO Date

Dec 11, 2020

Website

www.4dmoleculartherapeutics.com

Key Metrics TTM

Revenue

$88M

+383560.9% YoY

Net Income

-$161M

EPS (Diluted)

Free Cash Flow

-$130M

Revenue / Share

$1.30

Gross Margin

-12.4%

Operating Margin

-203.5%

Net Margin

-182.3%

FCF Margin

-147.4%

P/S

5.8x

P/E

Earnings Reports

Q1 2026

May 7, 2026

$3M+21664.3%

FY 2025

Mar 18, 2026

$85M+230194.6%

Q4 2025

Mar 18, 2026

$85M+8508900.0%

Q3 2025

Nov 10, 2025

$90.0K+2900.0%

Q2 2025

Aug 11, 2025

$15.0K+200.0%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee